Aims: To identify predictive embryonic markers of implantation in RIF, following pre-implantation genetic screening (PGS) of cleavage stage embryos, after accounting for male and female factors. 
BACKGROUND
Worldwide more than 1.5 million in vitro fertilisation (IVF) cycles are annually performed. 1 In Australia where single embryo transfer (ET) is the norm, in 2014, only 31.6% resulted in a clinical pregnancy, and less than a quarter resulted in a live birth.
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Of women undergoing IVF, approximately 10% will, unfortunately, experience recurrent embryo implantation failure (RIF), 3 variously defined as the failure of more than three, four or five successive embryos to implant, and may vary according to the stage at which the embryo is transferred. 3 Consequently, RIF is a significant cause of anxiety for couples undergoing IVF treatment, 4 and a significant area of research to determine predictive markers of successful embryo implantation. 5 Several putative male, female and embryological factors may limit embryo implantation, such as male and female age, and body mass index (BMI), cigarette smoking, thyroid disorder, endometriosis, the presence of fibroids, hydrosalpinges, metabolic disorder, a thrombophilia, high sperm DNA fragmentation, and the quality and chromosomal status of embryos transferred. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Consequently, it is important to correct any co-existing condition that may limit embryo implantation. However, as the embryo is predisposed to aneuploidy, the most important factor limiting implantation, 6 it is important to ensure the embryo for transfer is euploid. Pre-implantation genetic screening (PGS) using array comparative genomic hybridisation (CGH) to determine embryo ploidy status is frequently employed, [16] [17] [18] although being gradually superseded by next generation sequencing (NGS), which has a greater degree of resolution to detect abnormalities. [19] [20] [21] [22] As PGS excludes the majority of chromosomal abnormalities, it is a valuable tool to study the influence of several other co-existing variables within the patient, the embryo or laboratory techniques employed, on the chance of a successful pregnancy.
The purpose of our study was to determine predictive markers of successful embryo implantation after PGS, for women with RIF, after exclusion and treatment of male and female factors limiting implantation.
MATERIALS AND METHODS
A retrospective study of all patients with recurrent implanta- 
Frozen embryo transfer (FET) treatment regime
The protocols used for FET cycles utilised either a low-dose follicle-stimulating hormone stimulation or hormone replacement therapy (HRT), as previously described. 24 Embryos were frozen at the blastocyst stage of development at times equivalent to when sibling embryos were freshly transferred. Frozenthawed embryos were transferred within 3-4 h of warming when most embryos had shown some re-expansion of the blastocoel cavity. Generally, when a fresh embryo transfer was undertaken, the highest ranked embryo based on morphological criteria was chosen. 
Preimplantation genetic screening
pregnancy, 26 and a clinical pregnancy was classified by the presence of a fetal sac on ultrasound scan at 6-7 weeks gestation.
RESULTS
A total of 84 patient records for 140 IVF cycles were identified with PGS scheduled. Of these cycles, 12 were excluded as no embryo transfer was performed, in four instances a double embryo transfer was performed, and PGS and embryoscope culture was scheduled but not undertaken in 25 cycles. These cycles were excluded. Patient demographics are recorded in Tables 1 and 2. As many patients had previously undergone treatment at other clinics, data relating to the precise number of embryo transfers performed were incomplete. Sixty-three patients underwent the transfer of 99 single euploid embryos (two consecutive transfers (n = 17), three transfers (n = 6), four transfers (n = 1), five transfers (n = 1)). Of euploid embryos transferred, 48 were fresh and 51 were frozen. Overall 11 biochemical pregnancies and 36 clinical pregnancies resulted. Six pregnancies subsequently miscarried, resulting in 30 livebirth pregnancies. CPR and LBR were 27.1% and 20.8%, respectively, for fresh, and 45.1% and 39.2% for frozen ETs (P = 0.04 and P = 0.02, respectively, for the differences).
Of males enrolled in the study, 76 (77.6%) underwent SCSA analysis. No samples reached the threshold levels of 25% DFI or 15% high DNA staining, indicative of poor DNA integrity or high incidence of immature sperm, respectively. Consequently, this variable was not included as a variable in the regression analyses.
There was a tendency following both fresh and frozen transfers for CPR to be higher when greater numbers of cells were present at the time of biopsy: 15.4% (n = 13) and 39.5% (n = 86) were: underweight, 33% and 33% (n = 3); normal weight, 39%
and 36% (n = 70); overweight, 42% and 21% (n = 19); obese, 0% and 0% (n = 6) (CPR χ 2 = 2.47, P = 0.116; LBR χ 2 = 7.199, P = 0.007). Four of the six miscarriages after euploid ET occurred in women with a BMI >25 kg/m 2 ; two miscarriages occurred in normal weight women.
When the effects of patient age, cell number at biopsy, patient BMI and type of embryo transferred (fresh or frozen) were analysed concurrently, only embryo type (P = 0.041) significantly influenced CPR, and LBR was influenced by both embryo type (P = 0.024) and patient BMI (P = 0.040).
DISCUSSION
For women with RIF embarking on IVF, PGS offers the opportunity to determine whether embryo aneuploidy is a significant contributor to their previous unsuccessful treatment cycles. Furthermore, the opportunity to transfer a euploid embryo offers an increased chance of conception, over an embryo that is selected purely on the basis of its stage of development, 28 although nowadays increasingly the stage at which the embryo is biopsied is at the blastocyst stage. 28 However, at the time of the study cleavage stage biopsy was widely practised. One of the perceived benefits, at the time of this study, was that by performing an embryo biopsy at the cleavage stage, an opportunity was afforded for the patient to undergo a fresh embryo transfer. In comparison, with an embryo biopsied at the blastocyst stage, embryos need to be frozen awaiting the outcome of testing. Patients are then required to wait for several weeks until a frozen ET cycle could commence, and then the frozen, and subsequently thawed, blastocyst may be transferred.
It has been previously demonstrated that in comparison to unbiopsied embryos, the serum ßhCG at the time of pregnancy test is lower in embryos biopsied at the cleavage stage. 29 Furthermore, it has been demonstrated that the age of the woman at the time of the IVF cycle is negatively correlated to the initial serum ßhCG measurement, 30 and that the initial serum ßhCG concentration is higher subsequent to a frozen embryo transfer in comparison to a fresh embryo transfer.
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Our analysis clearly demonstrated that the transfer of a frozen euploid embryo was significantly more likely to result in a pregnancy than an embryo that was transferred in a fresh cycle.
The reason for this is believed to relate to the endometrium, in that in a frozen cycle the endometrial environment more closely resembles that of natural conception, in comparison to the supraphysiological environment generated in a fresh IVF cycle. 6 The possibility exists that the variant age of frozen-thawed embryos in comparison to fresh embryos may contribute to the apparent difference in pregnancy potential. However, the relatively short period of extended culture (3-4 h) of frozen embryos between thawing and subsequent transfer is unlikely to be sufficient to directly affect embryo viability.
The likelihood of pregnancy was also shown to be significantly greater if the embryo was more advanced in its devel- 
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Consequently our study suggests that the more advanced the embryo is at the time of biopsy, the more able it appears to withstand the biopsy process. In addition, to add strength to this assertion, the serum ßhCG concentration, a marker of embryonic development, at the initial pregnancy test is directly related to the number of blastomeres present within the embryo at the time of biopsy. Although after controlling for other variables, this significance was lost, due to a decrease in the power of the analysis after controlling for multiple variables. An interesting finding of our study was that after controlling for all variables, including ploidy status of the embryo, being overweight had a significant deleterious effect on the chance of a livebirth. This has been previously reported 32 in general IVF and oocyte recipient populations, without pre-implantation genetic screening, although not all the literature is in agreement.
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Notwithstanding the strength of our study in that we could control for many variables that may limit embryo implantation in our study of RIF patients, as we have a strict protocol to investigate such patients, our study has some limitations. The main limitation of the study is that it is a small retrospective study; however, the occurrence of RIF is low within an IVF population. A larger patient population would increase the power of the study to detect other embryo morphological characteristics limiting implantation of a euploid embryo. Further limitations to our study relate to the fact that now most IVF units perform blastocyst biopsy as standard approach to PGS, and the ploidy status of the embryos is increasingly being assessed by NGS. 19 However, as the field of reproductive medicine is continually evolving, it is important to critically evaluate all techniques before embracing new technologies and techniques.
CONCLUSION
This small observational study demonstrated that in patients with recurrent implantation failure, the transfer of a single euploid embryo within a frozen ET cycle was more successful than transferring it in a fresh cycle, and the initial serum ßhCG concentration after ET was predictive of a successful ongoing pregnancy. Furthermore, the number of blastomeres present at the time of embryo biopsy was predictive of the time taken to develop to a blastocyst, and of successful implantation and ongoing pregnancy.
